CHO-Based Assay Kit
Charles River’s HCP-ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.
Charles River’s HCP-ELISA Kit
Charles River Laboratories’ enzyme-linked immunosorbent assay (ELISA) kit is designed for the detection and quantitation of residual host cell proteins (HCP) in Chinese hamster ovary (CHO)-based biotherapeutics. Building on the company’s HCP-GAPex service, the HCP–ELISA kit is designed to increase the efficiency and efficacy of HCP assay development.
The HCP–ELISA kit has a 96-well assay plate and has a time-to-result of approximately three hours. It leverages avian immunoglobulin Y antibodies as the primary detection technology, which are derived from specific-pathogen-free chicken eggs developed exclusively by AVS Bio.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
